Home›Stock Screener›FDC›Quarterly Results

FDC Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹28 Cr
QSept 2025
Quarterly Results

In Sept 2025, FDC (FDC) reported revenue ₹494 Cr and net profit ₹28 Cr — revenue -10.0% YoY. Compare with FDC fundamental valuation to assess whether the stock is under or overvalued.

FDC Quarterly Results — Revenue, Profit & EPS Highlights

FDC latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit FDC stock price BSE.

  • Revenue of ₹494 Cr in Sept 2025 (-2.8% vs Mar 2025, -10.0% vs Sept 2024)
  • Net Profit of ₹28 Cr in Sept 2025 (-28.2% vs Mar 2025, -61.1% vs Sept 2024)
  • EBITDA of ₹54 Cr in Sept 2025 (-22.9% vs Mar 2025)
  • Operating Margin of 7.0% in Sept 2025 (-4.0pp vs Mar 2025)
  • Earnings Per Share of ₹1.75 in Sept 2025 (-26.5% vs Mar 2025)

FDC Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FDC quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 494 508 684 486 549 -2.8% -10.0%
Net Profit (₹ Cr) 28 39 121 28 72 - -
EBITDA (₹ Cr) 54 70 176 52 105 - -
EPS (₹) 1.75 2.38 7.45 1.74 4.43 - -
Operating Margin (%) 7.0% 11.0% 22.0% 7.0% 14.0% - -

FDC Share Price Trend — 1-Year Movement Across Quarterly Results

FDC 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore FDC share price charts to track price trends across different timeframes.

Profitability Ratios

Profit Margin 5.7%
EBITDA Margin 10.9%
Operating Margin 7.0%
ROE (Annual) 4.9%

Balance Sheet Highlights

Total Assets ₹2,714 Cr
Total Equity ₹2,281 Cr
Current Assets ₹1,089 Cr
Current Liabilities ₹71 Cr

Cash Flow Analysis

Operating Cash Flow ₹318 Cr
Investing Cash Flow ₹-199 Cr
Financing Cash Flow ₹-92 Cr
Net Cash Flow ₹26 Cr

Current Market Data

Current Price ₹429.55
Exchange NSE
Last Updated May 27, 2026

Revenue Trend (₹ Cr)

Dec 2025 486
Jun 2025 684
Mar 2025 508
Sept 2025 494

Net Profit Trend (₹ Cr)

Dec 2025 28
Jun 2025 121
Mar 2025 39
Sept 2025 28

Operating Margin Trend (%)

Dec 2025 7.0%
Jun 2025 22.0%
Mar 2025 11.0%
Sept 2025 7.0%

FDC vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

FDC latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹442,581.33 Cr 1844.3 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Mar 2026 		₹179,363.85 Cr 6797.5 2,986 751 +4.4% +11.8% 25.2% 240.1
Torrent Pharmaceuti…
Mar 2026 		₹153,579.77 Cr 4537.8 4,111 364 +27.7% +42.2% 8.9% 394.2
Cipla
Mar 2026 		₹114,559.46 Cr 1418.2 6,612 543 -14.3% -4.0% 8.2% 206.4
Dr Reddys Laborator…
Mar 2026 		₹110,089.41 Cr 1319.0 7,996 221 -12.5% -11.5% 2.8% 497.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores